197 related articles for article (PubMed ID: 7037214)
1. Toxicity, interstrand cross-links and DNA fragmentation induced by 'activated' cyclophosphamide in yeast: comparative studies on 4-hydroperoxy-cyclophosphamide, its monofunctional analogon, acrolein, phosphoramide mustard, and nor-nitrogen mustard.
Fleer R; Brendel M
Chem Biol Interact; 1982 Mar; 39(1):1-15. PubMed ID: 7037214
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
Crook TR; Souhami RL; McLean AE
Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
[TBL] [Abstract][Full Text] [Related]
4. The cytotoxic action of activated and non-activated cyclophosphamide in yeast: comparison of induced DNA damage.
Fleer R; Ruhland A; Brendel M
Chem Biol Interact; 1982 Oct; 42(1):67-78. PubMed ID: 6758963
[TBL] [Abstract][Full Text] [Related]
5. Effect of acrolein on phosphoramide mustard-induced sister chromatid exchanges in cultured human lymphocytes.
Wilmer JL; Erexson GL; Kligerman AD
Cancer Res; 1990 Aug; 50(15):4635-8. PubMed ID: 2369740
[TBL] [Abstract][Full Text] [Related]
6. Toxicity, interstrand cross-links and DNA fragmentation induced by 'activated' cyclophosphamide in yeast.
Fleer R; Brendel M
Chem Biol Interact; 1981 Oct; 37(1-2):123-40. PubMed ID: 7026063
[TBL] [Abstract][Full Text] [Related]
7. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.
Crook TR; Souhami RL; Whyman GD; McLean AE
Cancer Res; 1986 Oct; 46(10):5035-8. PubMed ID: 3463410
[TBL] [Abstract][Full Text] [Related]
8. Effects of 4-hydroperoxycyclophosphamide (4-OOH-CP) and 4-hydroperoxydechlorocyclophosphamide (4-OOH-deCICP) on the cell cycle of post implantation rat embryos.
Little SA; Mirkes PE
Teratology; 1992 Feb; 45(2):163-73. PubMed ID: 1615426
[TBL] [Abstract][Full Text] [Related]
9. Does acrolein contribute to the cytotoxicity of cyclophosphamide?
Wrabetz E; Peter G; Hohorst HJ
J Cancer Res Clin Oncol; 1980; 98(2):119-26. PubMed ID: 7217177
[TBL] [Abstract][Full Text] [Related]
10. Glutathione diminishes the anti-tumour activity of 4-hydroperoxycyclophosphamide by stabilising its spontaneous breakdown to alkylating metabolites.
Lee FY
Br J Cancer; 1991 Jan; 63(1):45-50. PubMed ID: 1989664
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
12. Reactions of nitrogen mustards with DNA.
Hemminki K; Kallama S
IARC Sci Publ; 1986; (78):55-70. PubMed ID: 3583398
[TBL] [Abstract][Full Text] [Related]
13. Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitro.
Mirkes PE; Greenaway JC; Rogers JG; Brundrett RB
Toxicol Appl Pharmacol; 1984 Feb; 72(2):281-91. PubMed ID: 6546458
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines.
Kohn FR; Sladek NE
Biochem Pharmacol; 1985 Oct; 34(19):3465-71. PubMed ID: 2996550
[TBL] [Abstract][Full Text] [Related]
15. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on the effects of cyclophosphamide on yeast in vitro and in the host-mediated assay: DNA damage and biological response.
Ogorek B; Fleer R; Mutschler E; Brendel M
Chem Biol Interact; 1981 Oct; 37(1-2):141-54. PubMed ID: 7026064
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
Friedman OM; Wodinsky I; Myles A
Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of drug-induced DNA effects in a nitrogen mustard resistant cell line expressing sensitivity to nitrosoureas.
Dean SW; Johnson AB; Tew KD
Biochem Pharmacol; 1986 Apr; 35(7):1171-6. PubMed ID: 2938589
[TBL] [Abstract][Full Text] [Related]
19. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
Spielmann H; Jacob-Müller U
Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
[TBL] [Abstract][Full Text] [Related]
20. De novo expression of transfected human class 1 aldehyde dehydrogenase (ALDH) causes resistance to oxazaphosphorine anti-cancer alkylating agents in hamster V79 cell lines. Elevated class 1 ALDH activity is closely correlated with reduction in DNA interstrand cross-linking and lethality.
Bunting KD; Townsend AJ
J Biol Chem; 1996 May; 271(20):11884-90. PubMed ID: 8662658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
